Acute Response to Unilateral Unipolar Electrical Carotid Sinus Stimulation in Patients With Resistant Arterial Hypertension.

PubWeight™: 0.81‹?›

🔗 View Article (PMID 26831195)

Published in Hypertension on February 01, 2016

Authors

Karsten Heusser1, Jens Tank1, Julia Brinkmann1, Jan Menne1, Jessica Kaufeld1, Silvia Linnenweber-Held1, Joachim Beige1, Mathias Wilhelmi1, André Diedrich1, Hermann Haller1, Jens Jordan2

Author Affiliations

1: From the Institute of Clinical Pharmacology (K.H., J.T., J.B., J.J.), Clinic for Nephrology (J.M., J.K., S.L.-H., H.H.), Division for Cardiothoracic, Transplantation- and Vascular Surgery (M.W.), Hannover Medical School, Hannover, Germany; Department of Nephrology and KfH Renal Unit, Hospital St. Georg, Leipzig, Germany (J.B.); and Division of Clinical Pharmacology, Department of Medicine, Autonomic Dysfunction Service, Vanderbilt University, Nashville, TN (A.D.).
2: From the Institute of Clinical Pharmacology (K.H., J.T., J.B., J.J.), Clinic for Nephrology (J.M., J.K., S.L.-H., H.H.), Division for Cardiothoracic, Transplantation- and Vascular Surgery (M.W.), Hannover Medical School, Hannover, Germany; Department of Nephrology and KfH Renal Unit, Hospital St. Georg, Leipzig, Germany (J.B.); and Division of Clinical Pharmacology, Department of Medicine, Autonomic Dysfunction Service, Vanderbilt University, Nashville, TN (A.D.). jordan.jens@mh-hannover.de.

Associated clinical trials:

CVRx Barostim Hypertension Pivotal Trial | NCT01679132

Articles cited by this

TOTAL THORACIC AND PARTIAL TO TOTAL LUMBAR SYMPATHECTOMY AND CELIAC GANGLIONECTOMY IN THE TREATMENT OF HYPERTENSION. Ann Surg (1941) 8.75

Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol (2011) 3.08

Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension (2005) 3.07

Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension (2010) 2.38

Differential control over postganglionic neurons in rat cardiac ganglia by NA and DmnX neurons: anatomical evidence. Am J Physiol Regul Integr Comp Physiol (2003) 2.20

Age and gender influence muscle sympathetic nerve activity at rest in healthy humans. Hypertension (1993) 2.19

Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction. JACC Heart Fail (2015) 2.12

Spatial resolution of cochlear implants: the electrical field and excitation of auditory afferents. Hear Res (1998) 1.99

Assessment of baroreceptor reflex sensitivity by means of spectral analysis. Hypertension (1987) 1.96

Interaction of baroreceptor and chemoreceptor reflex control of sympathetic nerve activity in normal humans. J Clin Invest (1991) 1.93

Prolonged activation of the baroreflex produces sustained hypotension. Hypertension (2004) 1.86

Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study. J Am Coll Cardiol (2010) 1.82

Evaluation of the baroreceptor-heart rate reflex by 24-hour intra-arterial blood pressure monitoring in humans. Hypertension (1988) 1.69

Evaluation of baroreceptor reflex by blood pressure monitoring in unanesthetized cats. Am J Physiol (1988) 1.64

Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects. Clin Pharmacol Ther (2006) 1.59

Prolonged activation of the baroreflex abolishes obesity-induced hypertension. Hypertension (2007) 1.48

Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy. Eur J Heart Fail (2015) 1.44

Gender difference in age-related changes in muscle sympathetic nerve activity in healthy subjects. Am J Physiol (1998) 1.44

The carotid body as a putative therapeutic target for the treatment of neurogenic hypertension. Nat Commun (2013) 1.32

Chronic carotid sinus nerve stimulation in the treatment of essential hypertension. Am J Surg (1967) 1.30

The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension. Exp Physiol (2011) 1.21

Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial. J Am Soc Hypertens (2012) 1.20

Gender differences in sympathetic nervous activity: influence of body mass and blood pressure. J Hypertens (2007) 1.12

Graded and dynamic reflex summation of myelinated and unmyelinated rat aortic baroreceptors. Am J Physiol (1999) 1.07

Hierarchical recruitment of the sympathetic and parasympathetic limbs of the baroreflex in normotensive and spontaneously hypertensive rats. J Physiol (2006) 1.05

Tonic activity of carotid body chemoreceptors contributes to the increased sympathetic drive in essential hypertension. Hypertens Res (2011) 1.04

Heterogeneity of autonomic regulation in hypertension and neurovascular contact. J Hypertens (2002) 0.89

Effect of bipolar electrode spacing on phrenic nerve stimulation and left ventricular pacing thresholds: an acute canine study. Circ Arrhythm Electrophysiol (2012) 0.88

Blood pressure control with selective vagal nerve stimulation and minimal side effects. J Neural Eng (2014) 0.86

Chronic baroreflex activation effects on sympathetic nerve traffic, baroreflex function, and cardiac haemodynamics in heart failure: a proof-of-concept study. Eur J Heart Fail (2014) 0.83

Bilateral carotid sinus nerve stimulation in the treatment of hypertension. Am J Cardiol (1972) 0.83

The effect of carotid sinus nerve stimulation on cardiovascular dynamics in man. Angiology (1969) 0.81

Reflex heart rate control via specific aortic nerve afferents in the rabbit. Circ Res (1975) 0.80

Truly refractory hypertension. Hypertension (2013) 0.77

Electrical carotid baroreceptor stimulation. Wien Med Wochenschr (2014) 0.77